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Introduction 
Dexamethasone (DEX), a synthetic long-acting corticosteroid, is extensively used in veterinary practice as it possesses major anti-inflammatory effects. Moreover, in pigs, 
immunomodulatory properties of this drug have been reported. In further research, DEX will be used in a porcine lipopolysaccharide (LPS) inflammation model as a positive control, 
however, exact data in literature on the disposition of DEX in pigs are lacking.  
The aim of this study was therefore to determine the pharmacokinetic (PK) parameters i.e. area under the curve, AUC; absorption and elimination rate constant, kabs and kel; half-life of 
absorption and elimination, T1/2abs and T1/2el; volume of distribution, Vd; clearance, Cl; maximum plasma concentration at 0 h, C0; maximum plasma concentration, Cmax; time to Cmax, 
Tmax and absolute bioavailability, F of DEX in pigs. 
Materials and Methods 
Experimental protocol 
The experiment was performed as a two-way cross-over design with each group containing three 
9-week-old male pigs. A wash-out period of 5 days was taken into account. The animals received 
a bolus of 0.3 mg/kg body weight DEX-sodium phosphate (DEXA 0.2%®, Kela Laboratories, see 
Fig. 1B) intravenously (IV) in the ear vein or intramuscularly (IM) in the m. gluteus. Blood was 
collected from the jugular vein before (time 0) and post-administration (0.25, 0.5, 0.75, 1, 2, 4, 
6, 8, 10, 12 and 24 hours). Plasma was stored at ≤ -15°C until analysis.  
 
DEX analysis 
Quantitation of the active form of DEX (Fig. 1A) in plasma was carried out using an in-house 
developed and validated liquid chromatography-tandem mass spectometry (LC-MS/MS) method. 
This is shown in Fig 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Chemical structures of DEX (A) and  Figure 2. Diagram of DEX analysis using a 
the ester prodrug, DEX-sodium phosphate (B) LC-MS/MS method  
 
 
PK and Statistical analysis 
The PK parameters were analyzed using WinNonlin, version 6.2.0 (Pharsight). A one-
compartmental model was used to determine the AUC0∞, kabs, kel, T1/2abs and T1/2el (expressed as 
the harmonic mean), Vd, Cl, C0, Cmax and Tmax.  
The absolute bioavailability (F) was calculated from the following equation:  
F (%) = (AUC0∞ IM / AUC0∞ IV ) × 100 
The data were statistically analysed by means of single-factor analysis of variance (ANOVA), 
using PASW Statistics 18 (IBM SPSS Software). A value of P<0.05 was considered significant. 
Parameter Units IV IM 
AUC0∞ h.ng/mL 133.07 ± 39.59 173.24 ± 53.59 
kabs /h - 12.90 ± 10.57 
kel /h 0.90 ± 0.28 0.65 ± 0.30 
T1/2abs h - 0.05
A  
T1/2el h 0.77
A 1.06A 
Vd L/kg 2.78 ± 0.88 3.04 ± 0.71 
Cl L/h.kg 2.39 ± 0.57 1.88 ± 0.60 
Tmax h - 0.35 ± 0.21 
C0 ng/mL 114.89 ± 26.56 - 
Cmax ng/mL - 80.94 ± 21.29 
F % - 131.06 ± 26.05 
Results 
The semi-logarithmic plots of the plasma concentration-time curves after IV and 
IM administration are depicted in Fig. 3. 
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Discussion and Conclusion 
In pigs, a remarkably high clearance of DEX is observed, which is noticeably faster than in other 
mammalian species.  It also resulted in a rather short half-life of elimination, notwithstanding the 
rather high volume of distribution.  
None of the pharmacokinetic parameters were significantly different between both administration 
routes. 
 
We can conclude that there is a complete and fast absorption as well as a fast 
elimination of the active substance of DEX-sodium phosphate following IM 
administration in pigs. 
 
 
 
 
 
 
 
Figure 3. Mean (± SD) plasma concentration-time profiles of dexamethasone 
after IV and IM bolus administration of 0.3 mg/kg BW in pigs (n=6)  
Table 1. Pharmacokinetic parameters for dexamethasone in pigs after IV and 
IM bolus administration of 0.3 mg/kg BW (n=6, mean ± SD) 
A:harmonic mean 
 
In future research, these pharmacokinetics will be applied in a 
porcine LPS-inflammation model to investigate the individual 
and synergistic immunomodulatory properties of DEX.  
The influence of DEX on the pro-inflammatory cytokines, acute 
phase proteins and fever suppression will be investigated. 
